CompletedPhase 4ketamine
Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial
Sponsored by University of Texas Southwestern Medical Center
NCT ID
NCT02643381
Target Enrollment
801 participants
Start Date
2016-06-06
Est. Completion
2020-12-01
About This Study
Patients who are having problems breathing sometimes require placement of a breathing tube in their mouth and windpipe. The purpose of this breathing tube is to save the patient's life. It is common to give the patient a medication to sedate him or her before the breathing tube is placed. For patients who are gravely ill two medications are commonly used: etomidate or ketamine. Both medications have risks and benefits. Researchers at UT-Southwestern Medical Center and Parkland Memorial Hospital would like to do a study to figure out which one is better for our patients.
Conditions Studied
Interventions
- •Etomidate
- •Ketamine
- •Emergency Endotracheal Intubation
- •Mechanical Ventilation
Eligibility
Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Adult patient (male or female) requiring emergency endotracheal intubation. Exclusion Criteria: * Children (\<18 years old). * Women who are known to be pregnant. * Any patient who has been previously randomized in the EvK Trial. * Patients who require endotracheal intubation without sedative medication. For example, patients in full cardiac arrest. * Patients with a known allergy to ketamine or etomidate. * Any individual wearing a MedAlert bracelet indicating that he/she has formally opted out of the EvK Trial.
Study Locations (1)
Parkland Hospital
Dallas, Texas, United States